Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients.
By O. Reich, C. Gratzke, A. Bachmann, M. Seitz, B. Schlenker, P. Hermanek, N. Lack, C. Stief. Journal of Urology, 2008
767 citations recorded by the source corpus.
Subfields: Pulmonary and Respiratory Medicine, Surgery, Urology
View Paper: https://www.semanticscholar.org/paper/52805d67fb66e93c6272ef6d26b438c915bbce90
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Oelke
- A. Bachmann
- S. Ahyai
- J. de la Rosette
- A. Descazeaud
- P. Gilling
- Mark Emberton
- S. Madersbacher
Citations in the corpus
- EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. (2013, background): “No studies on the optimal cut-off value are available, but the rate of complications increases with size [84].”
- Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. (2010, background): “However, despite innovations and improvements, TURP is still associated with significant morbidity, particularly in patients with larger prostates, indwelling catheters, bleeding disorders, or those who are undergoing anticoagulation therapy [2].”